Surgical management of pancreatic cancer liver oligometastases.
Carcinoma
Liver
Pancreatic Ductal
Standard of Care
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
26
10
2021
revised:
08
03
2022
accepted:
09
03
2022
pubmed:
19
3
2022
medline:
3
5
2022
entrez:
18
3
2022
Statut:
ppublish
Résumé
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer, which commonly metastasizes to the liver. The current standard of care for metastatic PDAC is systemic chemotherapy, however there are limited emerging data regarding surgical resection of pancreatic oligometastases in select patients. Here we review the literature addressing resection of PDAC liver oligometastases.
Identifiants
pubmed: 35301097
pii: S1040-8428(22)00078-6
doi: 10.1016/j.critrevonc.2022.103654
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103654Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.